Cancer Research Education Grants Program - Curriculum or Methods Development (R25 Clinical Trial Not Allowed)
Funding available for developing curriculum or methods for cancer research education programs supporting the training needs of the biomedical, behavioral, and clinical research workforce in the US.
Funder: National Institutes of Health
Due Dates: May 25, 2025 (New/Renewal/Resubmission/Revision) | September 25, 2025 (New/Renewal/Resubmission/Revision) | January 25, 2026 (New/Renewal/Resubmission/Revision) | May 25, 2026 (New/Renewal/Resubmission/Revision) | September 25, 2026 (New/Renewal/Resubmission/Revision)
Funding Amounts: Up to $150,000 direct costs per year, for a maximum of 2 years; indirect costs capped at 8% MTDC.
Summary: Supports innovative curriculum or methods development projects to enhance cancer research education for the biomedical, behavioral, and clinical research workforce.
Key Information: Clinical trials are not allowed; projects must be cancer-focused and not intended for undergraduate or lay audiences.
Description
This opportunity, offered by the National Cancer Institute (NCI) at NIH, funds the development of innovative curricula or methods to advance cancer research education. The program aims to enhance the training of the biomedical, behavioral, and clinical research workforce by supporting creative educational activities that address the cause, diagnosis, prevention, or treatment of cancer, rehabilitation, or continuing care for cancer patients and their families.
Projects should focus on the development, testing, and preparation for dissemination of new educational curricula or methods, including novel instructional approaches or computer-based tools. The expectation is that these resources will be adaptable and widely usable by the cancer research education community.
Note: This program does not support the actual delivery of the developed curriculum or methods to participants; it is strictly for development and preparation for dissemination.
